Adenine phosphoribosyltransferase deficiency with renal deposition of 2,8- dihydroxyadenine leading to nephrolithiasis and chronic renal failure

K. H. Fye, A. Sahota, D. C. Hancock, A. B. Gelb, J. Chen, J. W. Sparks, R. K. Sibley, J. A. Tischfield

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Homozygous adenine phosphoribosyltransferase deficiency is a genetic defect that is associated with 2,8-dihydroxyadenine urolithiasis. Since the prevalence of the heterozygous state is found in 0.4% to 1.2% of the population, it is surprising that more cases of 2,8-dihydroxyadenine urolithiasis have not been reported. Herein we describe a patient with complete adenine phosphoribosyltransferase deficiency with 2,8- dihydroxyadenine urolithiasis leading to chronic renal failure. Gene sequencing revealed that the patient is a compound heterozygote. One of the mutations (a T insertion between bases 346 and 347) has been encountered before, but the second (a G-to-A substitution at base 1356) has not been previously reported. Possible explanations for the unexpected rarity of 2,8- dihydroxyadenine urolithiasis are discussed.

Original languageEnglish (US)
Pages (from-to)767-770
Number of pages4
JournalArchives of Internal Medicine
Volume153
Issue number6
DOIs
StatePublished - 1993
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Fingerprint

Dive into the research topics of 'Adenine phosphoribosyltransferase deficiency with renal deposition of 2,8- dihydroxyadenine leading to nephrolithiasis and chronic renal failure'. Together they form a unique fingerprint.

Cite this